Methods and compositions for treating post-myocardial infarction damage

a myocardial infarction and composition technology, applied in the direction of peptide/protein ingredients, granular delivery, depsipeptides, etc., can solve the problems of blood clotting in the artery, and affecting the function of the myocardium

Inactive Publication Date: 2012-05-29
ABBOTT CARDIOVASCULAR
View PDF265 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Ischemic heart disease typically results from an imbalance between the myocardial blood flow and the metabolic demand of the myocardium.
However, an MI can also be a result of minor blockages where, for example, there is a rupture of the cholesterol plaque resulting in blood clotting within the artery.
Thus, the flow of blood is blocked and downstream cellular damage occurs.
This damage can cause irregular rhythms that can be fatal, even though the remaining muscle is strong enough to pump a sufficient amount of blood.
Such procedures do not, however, treat actual tissue damage to the heart.
An important component in the progression to heart failure is remodeling of the heart due to mismatched mechanical forces between the infracted region and the healthy tissue resulting in uneven stress and strain distribution in the left ventricle.
In other areas, remote regions experience hypertrophy (thickening) resulting in an overall enlargement of the left ventricle.
These changes also correlate with physiological changes that result in increase in blood pressure and worsening systolic and diastolic performance.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for treating post-myocardial infarction damage
  • Methods and compositions for treating post-myocardial infarction damage
  • Methods and compositions for treating post-myocardial infarction damage

Examples

Experimental program
Comparison scheme
Effect test

example

[0040]In one embodiment, collagen electrospun fibers can be processed to a range from about 200 nm and about 1300 nm. The range of electrospun fibers is approximately the range of naturally occurring type 1 and type 3 fibers which make up the heart matrix. Thus, the electrospun fibers may mimic endogenous fibers and accelerate growth of repair tissue to the infarct region, in particular, on the heart. The fibers can be dispersed throughout one component of a two-component gel. The two components can then be delivered to myocardial infarct region. The fibers can provide “docking sites” for endogenous myocardial stem cells and encourage their differentiation into cardiomyocytes. The gel can provide temporary containment of the fibers and prevent premature removal by macrophage cells.

[0041]The fibers can be fabricated such that they include an agent or no agent. Examples of agents can include a chemoattractant, such as SDF-1, or a cell survival promoting factor, such as IGF-1. In one e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
lengthsaaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

Methods and compositions for treating post-myocardial infarction damage are herein disclosed. In some embodiments, a carrier with a treatment agent may be fabricated. The carrier can be formulated from a bioerodable, sustained-release substance. The resultant loaded carrier may then be suspended in at least one component of a two-component matrix system for simultaneous delivery to a post-myocardial infarction treatment area.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This is a continuation-in-part of application Ser. No. 11 / 361,920, filed Feb. 23, 2006, which is a continuation-in-part of application Ser. No. 11 / 110,223, filed Apr. 19, 2005, now pending.FIELD OF INVENTION[0002]Post-myocardial infarction treatments and compositions.BACKGROUND OF INVENTION[0003]Ischemic heart disease typically results from an imbalance between the myocardial blood flow and the metabolic demand of the myocardium. Progressive atherosclerosis with increasing occlusion of coronary arteries leads to a reduction in coronary blood flow. “Atherosclerosis” is a type of arteriosclerosis in which cells including smooth muscle cells and macrophages, fatty substances, cholesterol, cellular waste product, calcium and fibrin build up in the inner lining of a body vessel. “Arteriosclerosis” refers to the thickening and hardening of arteries. Blood flow can be further decreased by additional events such as changes in circulation that lea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(United States)
IPC IPC(8): A61K9/127A61P7/00
CPCA61K9/0024A61K31/4439A61K31/557A61K31/56A61K38/30A61K47/36A61K38/27A61L27/52A61L27/26A61K38/195C08L5/08C08L89/06A61P7/00A61P9/10
Inventor MICHAL, EUGENEBASU, SHUBHAYUKUO, HAI-CHIEN
Owner ABBOTT CARDIOVASCULAR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap